Our primary research interest is to understand the role and the underlying mechanisms of heparan sulfate proteoglycans in angiogenesis, stem cell, hemostasis and leukoctye trafficking/inflammation with a long-term goal to develop novel therapeutics to improve the treatment of vascular diseases such as ischemia and stroke, inflamation and cancer et al. 

Supports from NIH (R01, R21, P41), Georgia Research Coalition and Am. Heart Association